The software-based intervention aims to reduce brain hypersensitivity in patients with migraine by modulating responses to environmental and internal stimuli through a 12-week program.

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

After proper training on subcutaneous injection technique, the prefilled syringe may be administered by the patient or caregiver.

When used with the companion app, the smart belt automatically alerts caregivers when a fall or impact is detected.

The randomized, double-blind, placebo-controlled ODYSSEY-HCM trial included 580 adult patients with symptomatic nonobstructive HCM.

CJD is caused by infectious proteins called prions. These proteins damage the brain and lead to fast-moving dementia.

To achieve these ends, the FDA will use computer modeling and artificial intelligence (AI) to predict a drug’s behavior and promote the use of lab-grown human organoids (tiny, self-organized ...

The recall involves the "Brunch & Go" stroller toy, a set of make-believe breakfast items including avocado toast, bacon, a tomato and an egg.

In the past, experts from the CDC’s EpiAid program have provided short-term help to local agencies dealing with urgent public health issues.

Patients carrying 2 copies of the APOE4 gene (APOE4/4 homozygotes) are more likely to develop AD earlier in life than those without APOE4.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.